TruBridge ROE 2012-2025 | TBRG
Current and historical return on equity (ROE) values for TruBridge (TBRG) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| TruBridge ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-09-30 | $0.00B | $0.18B | 1.74% |
| 2025-06-30 | $-0.01B | $0.17B | -6.43% |
| 2025-03-31 | $-0.02B | $0.17B | -10.40% |
| 2024-12-31 | $-0.02B | $0.17B | -11.30% |
| 2024-09-30 | $-0.06B | $0.17B | -32.64% |
| 2024-06-30 | $-0.05B | $0.18B | -27.25% |
| 2024-03-31 | $-0.05B | $0.19B | -25.12% |
| 2023-12-31 | $-0.05B | $0.18B | -21.44% |
| 2023-09-30 | $0.00B | $0.23B | -0.43% |
| 2023-06-30 | $0.00B | $0.23B | 1.72% |
| 2023-03-31 | $0.01B | $0.23B | 4.29% |
| 2022-12-31 | $0.02B | $0.23B | 6.46% |
| 2022-09-30 | $0.02B | $0.23B | 7.83% |
| 2022-06-30 | $0.02B | $0.23B | 8.42% |
| 2022-03-31 | $0.02B | $0.23B | 9.98% |
| 2021-12-31 | $0.02B | $0.22B | 8.42% |
| 2021-09-30 | $0.02B | $0.22B | 7.69% |
| 2021-06-30 | $0.02B | $0.21B | 8.87% |
| 2021-03-31 | $0.01B | $0.20B | 7.08% |
| 2020-12-31 | $0.01B | $0.20B | 7.22% |
| 2020-09-30 | $0.02B | $0.20B | 11.58% |
| 2020-06-30 | $0.02B | $0.19B | 11.41% |
| 2020-03-31 | $0.02B | $0.19B | 11.80% |
| 2019-12-31 | $0.02B | $0.18B | 11.64% |
| 2019-09-30 | $0.02B | $0.17B | 9.65% |
| 2019-06-30 | $0.02B | $0.17B | 11.21% |
| 2019-03-31 | $0.02B | $0.16B | 10.34% |
| 2018-12-31 | $0.02B | $0.16B | 11.37% |
| 2018-09-30 | $-0.01B | $0.15B | -7.67% |
| 2018-06-30 | $-0.02B | $0.14B | -10.34% |
| 2018-03-31 | $-0.01B | $0.14B | -8.77% |
| 2017-12-31 | $-0.02B | $0.14B | -11.22% |
| 2017-09-30 | $0.01B | $0.16B | 3.82% |
| 2017-06-30 | $0.01B | $0.16B | 3.83% |
| 2017-03-31 | $0.01B | $0.16B | 3.82% |
| 2016-12-31 | $0.00B | $0.16B | 2.52% |
| 2016-09-30 | $0.01B | $0.16B | 3.62% |
| 2016-06-30 | $0.01B | $0.16B | 5.06% |
| 2016-03-31 | $0.01B | $0.16B | 10.10% |
| 2015-12-31 | $0.02B | $0.08B | 21.66% |
| 2015-09-30 | $0.02B | $0.08B | 26.25% |
| 2015-06-30 | $0.03B | $0.08B | 33.64% |
| 2015-03-31 | $0.03B | $0.08B | 37.97% |
| 2014-12-31 | $0.03B | $0.08B | 43.14% |
| 2014-09-30 | $0.04B | $0.08B | 48.98% |
| 2014-06-30 | $0.03B | $0.08B | 48.75% |
| 2014-03-31 | $0.03B | $0.07B | 49.62% |
| 2013-12-31 | $0.03B | $0.07B | 50.39% |
| 2013-09-30 | $0.03B | $0.06B | 51.24% |
| 2013-06-30 | $0.03B | $0.06B | 51.24% |
| 2013-03-31 | $0.03B | $0.06B | 51.24% |
| 2012-12-31 | $0.03B | $0.06B | 49.79% |
| 2012-09-30 | $0.03B | $0.06B | 46.47% |
| 2012-06-30 | $0.03B | $0.06B | 46.75% |
| 2012-03-31 | $0.03B | $0.06B | 48.87% |
| 2011-12-31 | $0.03B | $0.06B | 49.29% |
| 2011-09-30 | $0.03B | $0.05B | 52.00% |
| 2011-06-30 | $0.03B | $0.05B | 52.63% |
| 2011-03-31 | $0.02B | $0.05B | 46.67% |
| 2010-12-31 | $0.02B | $0.05B | 43.68% |
| 2010-09-30 | $0.02B | $0.04B | 37.43% |
| 2010-06-30 | $0.02B | $0.04B | 35.29% |
| 2010-03-31 | $0.02B | $0.04B | 35.29% |
| 2009-12-31 | $0.02B | $0.04B | 37.65% |
| 2009-09-30 | $0.02B | $0.04B | 40.48% |
| 2009-06-30 | $0.02B | $0.04B | 41.46% |
| 2009-03-31 | $0.02B | $0.04B | 40.00% |
| 2008-12-31 | $0.02B | $0.04B | 41.03% |
| 2008-09-30 | $0.02B | $0.04B | 39.22% |
| 2008-06-30 | $0.01B | $0.04B | 36.84% |
| 2008-03-31 | $0.01B | $0.04B | 36.84% |
| 2007-12-31 | $0.01B | $0.04B | 34.21% |
| 2007-09-30 | $0.01B | $0.04B | 33.99% |
| 2007-06-30 | $0.01B | $0.04B | 33.99% |
| 2007-03-31 | $0.01B | $0.04B | 36.60% |
| 2006-12-31 | $0.02B | $0.04B | 39.47% |
| 2006-09-30 | $0.02B | $0.04B | 40.27% |
| 2006-06-30 | $0.02B | $0.04B | 44.14% |
| 2006-03-31 | $0.02B | $0.04B | 43.17% |
| 2005-12-31 | $0.01B | $0.04B | 42.75% |
| 2005-09-30 | $0.01B | $0.03B | 42.28% |
| 2005-06-30 | $0.01B | $0.03B | 38.26% |
| 2005-03-31 | $0.01B | $0.03B | 33.33% |
| 2004-12-31 | $0.01B | $0.03B | 26.92% |
| 2004-09-30 | $0.01B | $0.03B | 23.53% |
| 2004-06-30 | $0.01B | $0.03B | 20.00% |
| 2004-03-31 | $0.01B | $0.03B | 24.24% |
| 2003-12-31 | $0.01B | $0.03B | 28.87% |
| 2003-09-30 | $0.01B | $0.02B | 30.77% |
| 2003-06-30 | $0.01B | $0.02B | 37.21% |
| 2003-03-31 | $0.01B | $0.02B | 45.57% |
| 2002-12-31 | $0.01B | $0.02B | 71.43% |
| 2002-09-30 | $0.01B | $0.02B | 111.11% |
| 2002-06-30 | $0.01B | $0.02B | 235.29% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.293B | $0.339B |
| TruBridge Inc. is a healthcare solutions company. TruBridge Inc. is based in MOBILE, Ala. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $28.621B | 33.10 |
| Tempus AI (TEM) | United States | $9.242B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.646B | 0.00 |
| Doximity (DOCS) | United States | $4.621B | 20.02 |
| Hims & Hers Health (HIMS) | United States | $3.711B | 30.18 |
| Hinge Health (HNGE) | United States | $3.065B | 0.00 |
| Privia Health (PRVA) | United States | $2.754B | 172.23 |
| 10x Genomics (TXG) | United States | $2.293B | 0.00 |
| Heartflow (HTFL) | United States | $1.759B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.736B | 23.16 |
| Omnicell (OMCL) | United States | $1.638B | 45.62 |
| Azenta (AZTA) | United States | $1.318B | 53.00 |
| Enovis (ENOV) | United States | $1.245B | 6.54 |
| Clover Health Investments (CLOV) | United States | $1.044B | 0.00 |
| Schrodinger (SDGR) | United States | $0.840B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.768B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.724B | 0.00 |
| Phreesia (PHR) | United States | $0.720B | 0.00 |
| Talkspace (TALK) | United States | $0.625B | 125.67 |
| Standard BioTools (LAB) | United States | $0.431B | 0.00 |
| Claritev (CTEV) | United States | $0.380B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.338B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.320B | 0.00 |
| Evolent Health (EVH) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.307B | 0.00 |
| Carlsmed (CARL) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.216B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.160B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.151B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.130B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 5.40 |
| American Well (AMWL) | United States | $0.088B | 0.00 |
| 111 (YI) | China | $0.070B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| Outset Medical (OM) | United States | $0.062B | 0.00 |
| Pulmonx (LUNG) | United States | $0.061B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.041B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.032B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.017B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| Movano (MOVE) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.005B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.002B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |